User Manual Q&AAnswer
Jan 13, 2025 - 01:06 AM
The Bosentan REMS program stands for Risk Evaluation and Mitigation Strategy. It is a program implemented by the manufacturers of bosentan, a medication used to treat pulmonary arterial hypertension (PAH). The purpose of the Bosentan REMS program is to ensure the safe and appropriate use of bosentan due to its potential risks and side effects.
Pharmacies are required to enroll in the Bosentan REMS program to ensure that they have the necessary knowledge and processes in place to safely dispense bosentan to patients. By enrolling, pharmacies agree to comply with the requirements outlined in the program, including training staff, verifying patient enrollment and care, completing necessary testing and counseling, reporting adverse events and pregnancies, and maintaining records.
Enrollment in the Bosentan REMS program is important to ensure that patients receive the medication safely and that any potential risks are minimized. It helps to ensure that all pharmacies handling bosentan are following the necessary protocols and procedures to protect patient safety.
If you have further questions or need additional information about the Bosentan REMS program, you can visit the website www.BosentanREMSProgram.com or contact the Bosentan REMS at 1-866-359-2612.
Add New Comment